Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01123889 · ClinicalTrials.gov registry record · NA
Treatment of the Rotator Cuff Disease With Platelet Rich Plasma Injection
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01123889 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 12 participants.
The verdict
NCT01123889, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this investigator initiated study is to clinically evaluate the efficacy of a new treatment for subacromial impingement syndrome and partial thickness rotator cuff tears. This treatment consists of a platelet rich plasma injection into and around the rotator cuff. It is thought that this treatment will dramatically improve outcomes for patients suffering from these two conditions. Subjects will be randomized by choosing a slip of paper from an envelope. This process will randomize 25 patients to the experimental group, and 25 patients to the control. The experimental group will undergo a blood draw, allowing for an injection of platelet rich plasma around the rotator cuff. The control group will undergo a corticosteroid injection into the subacromial space surrounding the rotator cuff as sole treatment. Patients will be followed for three months for pain, and will fill out questionnaires at six weeks and three months post injection, which will give insight into functionality and pain changes that the rotator cuff is experiencing due to treatment. Subjects will be outpatients. Subjects may include employees, students, minorities, and elderly, although no subsets of these will be formed. Subjects will be between 18 and 89 years of age. In total, subject participation will last approximately 3 months.
Interventions
- BIOLOGICAL platelet rich plasma injection
- DRUG corticosteroid injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01123889
The ClinicalTrials.gov registry entry for NCT01123889 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which platelet rich plasma injection is the first listed.
NCT01123889 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01123889 about?
NCT01123889 is a clinical study titled "Treatment of the Rotator Cuff Disease With Platelet Rich Plasma Injection". The purpose of this investigator initiated study is to clinically evaluate the efficacy of a new treatment for subacromial impingement syndrome and partial thickness rotator cuff tears. This treatment consists of a platelet rich plasma injection into and around the rotator cuff. It is thought that t...
What is the current status of trial NCT01123889?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2010-05. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01123889?
The interventions under investigation include: platelet rich plasma injection (BIOLOGICAL), corticosteroid injection (DRUG).
Who is sponsoring clinical trial NCT01123889?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.